Articles |
Presented in part in abstract form (Biophys J. 1995;68:12).
From the Department of Physiology, Loyola University of Chicago, Stritch School of Medicine, Maywood, Ill.
Correspondence to Stephen L. Lipsius, PhD, Department of Physiology, Loyola University Medical Center, 2160 S First Ave, Maywood, IL 60153.
| Abstract |
|---|
|
|
|---|
Key Words: perforated patch muscarinic receptors cAMP forskolin phosphoinositol calcium
| Introduction |
|---|
|
|
|---|
The response of atrial myocytes to ISO can be altered by the ruptured-patch recording method, presumably because of cell dialysis.11 In the present study, therefore, we used a nystatinperforated patch12 whole-cell recording method to minimize alterations in the intracellular milieu and thereby preserve intracellular signaling processes. The present experiments indicate that prior exposure to ISO induces ACh to activate a GLIB-sensitive K+ current, presumably IK,ATP. The effect of ISO to potentiate ACh-induced increases in K+ conductance is a novel mechanism that may contribute to accentuated cholinergic antagonism of atrial function.
| Materials and Methods |
|---|
|
|
|---|
5 minutes followed by a 5-minute
perfusion with a nominally Ca2+-free Tyrode's
solution and then a 30- to 40-minute perfusion with low (36 µmol/L)
Ca2+ Tyrode's solution containing 0.06%
collagenase (Worthington Biochemical, type II). After
collagenase perfusion, both atria were cut into small
pieces and agitated in fresh collagenase and 0.01%
protease. Experiments were performed on either right or left atrial
cells, with no discernible differences.
Cells used for study were transferred to a small (0.3-mL) tissue bath
on the stage of an inverted microscope (Nikon Diaphot) and superfused
with a modified Tyrode's solution containing (in mmol/L) NaCl 137, KCl
5.4, MgCl2 1.0, CaCl2 2.5, HEPES 5, and glucose
11 and titrated with NaOH to a pH of 7.4. Solutions were perfused by
gravity at
5 mL/min, and experiments were performed at 35±1°C.
Cells studied were isolated on the same morning as each experiment, and
those selected for study were elongated and quiescent. Voltage and
ionic currents were recorded by using a nystatinperforated
patch12 whole-cell recording
method.14 This method minimizes dialysis of intracellular
constituents with the internal pipette solution. Nystatin was dissolved
in dimethyl sulfoxide at a concentration of 50 mg/mL and then added to
the internal pipette solution to yield a final nystatin concentration
of 150 µg/mL. The internal pipette solution contained (in mmol/L)
potassium glutamate 100, KCl 40, MgCl2 1.0,
Na2-ATP 4, EGTA 0.5, and HEPES 5 and was titrated with KOH
to a pH of 7.2. Pipettes had inner diameters of 1 to 1.5 µm and, when
filled with internal solution, had resistances of 2 to 3 M
. Once a
gigaseal was formed, access resistance decreased to as low as 15 M
after
5 to 10 minutes.
Our standard experimental protocol involved an initial 30-second ACh
exposure (ACh1) followed by a 6-minute recovery period in
ACh-free solution and then a second 30-second ACh exposure
(ACh2) (see Fig 1
). In most experiments,
ICa,L was activated by depolarizing voltage-clamp
pulses imposed during the recovery period between ACh1 and
ACh2. In general, experimental interventions such as
exposure to ISO, forskolin, and BAY K 8644 were also imposed during the
6-minute recovery period, after ACh1 and before
ACh2, unless stated otherwise. In this way, we
determined the effect of each experimental intervention on ACh-induced
K+ conductances by comparing the response to
ACh2 in relation to ACh1. Voltage-clamp ramps
(40 mV/s) between -130 and +30 mV were imposed during and after each
ACh exposure to assess changes in total membrane conductance. Voltage
ramps were delivered during the administering of ACh at the peak
increase in ACh-induced K+ conductance, ie, within
1
second. In some experiments, steady state I-V relations were generated
by clamping from a holding potential of -40 mV to more positive and
negative voltages for 2 seconds in 10-mV increments. Steady state
currents were measured at the end of each clamp step. In these
experiments, external solutions contained 1 µmol/L
verapamil to block ICa,L and 1 mmol/L
4-aminopyridine to block transient outward current, respectively.
Activation of ICa,L was elicited by voltage-clamp steps
from a holding potential of -40 to 0 mV for 200 milliseconds at 0.5
Hz. Current densities (pA/pF) were determined by normalizing currents
to total cell capacitance.15
|
A single suction pipette recorded voltage (bridge mode) or ionic
currents (discontinuous voltage-clamp mode) by use of an Axoclamp 2A
amplifier (Axon Instruments, Inc). In the voltage-clamp mode, the
sample rate was
10 to 12 kHz. A second scope was used to monitor the
duty cycle to ensure complete settling of the voltage transient between
samples. Computer software (PCLAMP, Axon Instruments,
Inc) was used to deliver voltage protocols and to acquire and
analyze data. All signals were digitally recorded on VCR
tape.
Drugs included ACh (Sigma Chemical Co), ISO (Sigma), forskolin (Sigma), Rp-cAMPs (LC Laboratories), ryanodine (Progressive Agri-Systems, Inc), 8-CPT-cAMP (Sigma), BAY K 8644 (a generous gift from Miles, Inc), thapsigargin (Sigma), atropine (Sigma), AFDX116 (a generous gift from Boehringer Ingelheim), calphostin C (Kamiya Biomedical Co), pirenzepine (Sigma), propranolol (Sigma), and GLIB (Sigma). Statistical significance of paired and unpaired data was determined by Student's t test and at P<.05. Data are expressed as mean±SEM.
| Results |
|---|
|
|
|---|
|
Effect of GLIB
Our previous study10 indicates that under appropriate
conditions ACh can activate two separate K+
currents: IK,ACh and a K+ current that is
inhibited by GLIB, a specific blocker of IK,ATP in cardiac
muscle.16 17 In Fig 2A
, we determined
whether the ACh2-induced K+ current potentiated
by ISO was selectively blocked by 10 µmol/L GLIB. GLIB was
administered throughout the experiment, and 1 µmol/L ISO and
ICa,L activation were imposed during the recovery period.
Although GLIB had no effect on background K+ currents, it
selectively blocked the ACh2-induced K+ current
potentiated by ISO. In the four cells studied, the ACh1-
and ACh2-induced K+ currents at -130 mV were
11.3±1.7 and 11.6±1.8 pA/pF, respectively, and those at +30 mV were
19.5±3.9 and 19.8±3.9 pA/pF, respectively. These results suggest that
the ACh2-induced K+ current potentiated by ISO
is IK,ATP.
|
In Fig 2B
, we compared the mean I-V relations for the
ACh2-induced K+ current potentiated by ISO
(
) and the GLIB-sensitive K+ current (
). The I-V
relation of the potentiated ACh2-induced K+
current was determined from the mean data presented in Fig 1B
.
Background currents were subtracted from the respective ACh-induced
K+ currents, and then the currents induced by
ACh1 were subtracted from those induced by
ACh2. The GLIB-sensitive K+ current was
determined by using the mean data from two different groups of cells.
The GLIB-insensitive K+ current, as shown in Fig 2A
, was
subtracted from the total K+ current induced by
ACh2 under control conditions, as shown in Fig 1B
. It is
apparent that both I-V relations exhibit similar features. Both
currents exhibited a linear conductance at voltages negative to
-50
mV and inwardly rectified at more positive voltages. Moreover, the
reversal potential and slope conductance of the potentiated
ACh2-induced K+ current (-83±2 mV, 133±17
pS/pF) were not statistically different from those of the
GLIB-sensitive K+ current (-79±1 mV, 110±27 pS/pF)
(n=4).
In Fig 3
, we further characterized the
ACh-activated GLIB-sensitive K+ current by
determining its steady state I-V relation by use of voltage-clamp
steps. In these experiments, cells were exposed to 1 µmol/L ISO plus
ICa,L activation for 6 minutes, followed by exposure to 10
µmol/L ACh. Clamp steps between -120 and +20 mV were imposed during
continuous exposure to ACh in the absence and then presence of 10
µmol/L GLIB. Fig 3A
shows original ACh-activated
GLIB-sensitive K+ currents determined by subtracting
currents obtained in the presence from those in the absence of GLIB. As
shown, the currents are time independent and inwardly rectifying and
are relatively noisy at positive voltages. These features are
consistent with those of IK,ATP.18 In
Fig 3B
, the steady state I-V relation shows a reversal potential of
-82 mV and a slope conductance of 151 pS/pF. In a total of three
cells, the mean slope conductance was 147±6 pS/pF, and the reversal
potential was 80±1 mV. These values are similar to those of the
ACh-activated GLIB-sensitive K+ currents obtained
with voltage ramps (Fig 2B
).
|
In four additional cells, we used DNP, a metabolic
inhibitor that lowers intracellular ATP levels and thereby
activates IK,ATP in cardiac muscle.19
Voltage-clamp ramps were used to assess K+ conductances.
DNP (100 µmol/L) induced an increase in current at voltages both
negative and positive to the reversal potential that was blocked by 10
µmol/L GLIB (not shown). The mean slope conductance (148±15 pS/pF)
and reversal potential (82±1 mV) of the DNP-induced K+
currents were not statistically different from those of the
ACh2-induced K+ currents potentiated by ISO
(see Fig 2B
).
Effects of ISO Are Mediated via cAMP
The next several experiments were designed to determine the
possible mechanisms responsible for the effects of ISO to elicit
ACh-activated IK,ATP. If the effects of ISO are
mediated, as expected, via stimulation of cAMP, then forskolin should
mimic the effects of ISO. In Fig 4A
, the experimental
protocol was repeated with 1 µmol/L forskolin plus ICa,L
activation imposed during the recovery period. Forskolin increased mean
basal ICa,L amplitude by 260% (n=3), which was comparable
to that induced by ISO (not shown). Like ISO, forskolin had no effect
on background current. After the 6-minute exposure to forskolin,
ACh2 induced a larger increase in K+
conductance than ACh1 at voltages both positive and
negative to the reversal potential. In the five cells studied, after
subtraction of background currents, ACh1- and
ACh2-induced K+ currents elicited at -130 mV
were 18.7±4.0 and 23.3±3.4 pA/pF, respectively (P<.02),
and those at +30 were 20.4±2.5 and 25.4±2.4 pA/pF, respectively
(P<.03). These values are comparable to those elicited by
ISO (Fig 1B
and Table
) and strongly suggest that the effects of ISO are
mediated via cAMP.
|
If cAMP mediates the effects of ISO, then directly increasing intracellular cAMP should also mimic the effects of ISO. Therefore, we determined whether 8-CPT-cAMP, a membrane-permeable analogue of cAMP that directly activates PKA, could potentiate ACh2-induced increases in K+ current. ICa,L activation and exposure to 200 µmol/L 8-CPT-cAMP were imposed during the period between ACh1 and ACh2. 8-CPT-cAMP increased mean basal ICa,L by 203% (n=5), which was comparable to the effects of ISO or forskolin. Under these conditions, ACh2 elicited a significantly larger increase in K+ current than ACh1 at voltages both positive and negative to the reversal potential. In a total of five cells, after subtraction of background currents, ACh1- and ACh2-induced K+ currents elicited at -130 mV were 13.0±1.5 and 17.2±2.2 pA/pF, respectively (P<.01), and those elicited at +30 were 13.4±1.1 and 17.2±1.6 pA/pF, respectively (P<.02).
One possible explanation of these findings is that ISO, forskolin, and
8-CPT-cAMP each stimulate Ca2+ influx via
ICa,L, and the additional intracellular
Ca2+ somehow stimulates ACh2 to
activate IK,ATP. If this hypothesis is correct,
then stimulation of ICa,L by BAY K 8644 should also mimic
the effects of each of these agents. BAY K 8644 is a direct L-type
Ca2+ channel agonist20 that does not
act via cAMP. In Fig 4B
, 0.5 µmol/L BAY K 8644 and ICa,L
activation were imposed during the recovery period. Although BAY K 8644
increased mean basal ICa,L by +197% (not shown),
ACh2-induced activation of K+ current was only
modestly potentiated compared with ACh1. In the three cells
studied, K+ currents induced by ACh1 and
ACh2 at -130 mV were 12.1±1.4 and 14.0±1.8 pA/pF,
respectively, and those at +30 mV were 13.2±2.0 and 15.0±2.5 pA/pF,
respectively. These findings suggest that enhanced
Ca2+ influx via ICa,L alone cannot
account for the effects of ISO to induce ACh-activated
IK,ATP.
Contribution of ICa,L
In the experiments shown in Fig 5A
, we assessed the
contribution made by ICa,L to the effects of ISO. ACh was
administered three consecutive times for 30 seconds each. ISO was
administered during both 6-minute recovery periods between each ACh
exposure. ICa,L activation, however, was imposed only
during the second recovery period between ACh2 and
ACh3. After the initial exposure to ISO alone,
ACh2 elicited an increase in K+ conductance
that was modestly larger than ACh1 at voltages negative and
positive to the reversal potential. In a total of eight cells, ISO
alone potentiated ACh2-induced compared with
ACh1-induced K+ current by +12.5±5.5% (-130
mV) and +13.0±2.1% (+30 mV). When ICa,L was
activated in conjunction with exposure to ISO during the second
recovery period, the ACh3-induced increase in
K+ conductance was markedly potentiated. Compared with the
response to ACh2, ACh3 elicited a
further increase in K+ current of +55.7±8.3% (-130 mV)
and +31.5±11.5% (+30 mV) (n=5). When compared with
ACh1, ACh3 increased K+
current by +76.5±9.3% (-130 mV) and +49.1±15.7% (+30 mV) (n=5).
Clearly, the ability of ISO to potentiate ACh-induced increases in
K+ conductance is significantly enhanced by
ICa,L activation.
|
Another important way of assessing the role of ICa,L in the
effects of ISO is to repeat the standard protocol in the presence of
nisoldipine, a selective blocker of ICa,L. Nisoldipine (1
µmol/L) blocked all inward current via ICa,L stimulated
during the recovery period (not shown). The original records in Fig 5B
show that in the presence of nisoldipine, ACh1 and
ACh2 induced a similar increase in K+ current;
ie, ACh2-activated IK,ATP was
selectively abolished by blocking ICa,L. In a total of four
cells, there were no differences between currents induced by
ACh1 and ACh2 in the presence of nisoldipine.
In another series of experiments, we determined the effect of omitting
Ca2+ from the external solution throughout the
experiment (data not shown). Removing external Ca2+
also abolished inward current via ICa,L. Without external
Ca2+, ACh1 and ACh2
elicited increases in K+ current that were not
significantly different from one another at voltages positive and
negative to the reversal potential (n=5). These results indicate that
blocking Ca2+ influx via ICa,L
selectively inhibits ISO-induced ACh2-activated
IK,ATP. Moreover, these findings suggest that although
Ca2+ influx via ICa,L alone is not
sufficient, it is essential for ISO to induce ACh-activated
IK,ATP.
Accumulation of SR Ca2+
Clearly, the present experiments indicate that the effects of
ISO are mediated by cAMP. In addition to stimulating ICa,L
amplitude, cAMP enhances SR Ca2+ uptake. Therefore,
in two series of experiments we tested either thapsigargin, an
inhibitor of SR Ca2+
uptake,21 or ryanodine, an alkaloid that opens SR
Ca2+ release channels22 and prevents
accumulation of SR Ca2+. Each drug was administered
from the beginning of its respective experiment, ie, throughout both
ACh1 and ACh2. As usual, ISO and
ICa,L activation were imposed during the period between
ACh1 and ACh2. In the presence of 5 µmol/L
thapsigargin, K+ currents induced by ACh1 and
ACh2 at -130 mV were 14.2±1.4 and 15.2±1.3 pA/pF,
respectively, and those at +30 mV were 15.8±1.8 and 15.1±1.5 pA/pF,
respectively (n=5) (see Table
). In the presence of 1 µmol/L
ryanodine, K+ currents induced by ACh1 and
ACh2 at -130 mV were 13.6±1.5 and 14.1±1.5 pA/pF,
respectively, and those at +30 mV were 16.4±3.5 and 15.2±2.4 pA/pF,
respectively (n=4) (see Table
). These results indicate that by
inhibiting the accumulation of SR Ca2+, these
agents selectively abolished the effect of ISO to potentiate
ACh2-induced K+ current. It is important to
note that in the presence of either thapsigargin or ryanodine, ISO
elicited a typical increase in ICa,L amplitude (not shown).
In another series of experiments, we tested the effects of Rp-cAMPs, a
specific inhibitor of cAMP-dependent PKA.23
Rp-cAMPs was administered throughout both ACh1 and
ACh2. In the presence of 50 µmol/L Rp-cAMPs,
ACh1- and ACh2-induced K+ currents
at -130 mV were 12.3±1.6 and 12.9±1.6 pA/pF, respectively, and those
at +30 mV were 16.2±2.2 and 15.7±2.4 pA/pF, respectively (n=5). These
results indicate that inhibition of cAMP-dependent PKA selectively
abolished the ACh2-induced increase in K+
current potentiated by ISO. Although Rp-cAMPs also prevented
ISO-induced stimulation of ICa,L (not shown), these
experiments collectively suggest that the conditioning effect of ISO
requires cAMP-mediated stimulation of SR Ca2+ uptake
and accumulation.
ß-Adrenergic and Muscarinic Receptor Subtypes
In the next few experiments, we examined the surface receptors
mediating the effects of ISO and ACh. As shown in Fig 6A
, 1 µmol/L ACh was administered three consecutive
times separated by two 6-minute recovery periods. ISO (1 µmol/L) and
ICa,L activation were imposed during the recovery periods
between each ACh exposure. Propranolol (2 µmol/L) was
administered after ACh2, throughout the second
recovery period, and during ACh3. As shown,
ACh1 elicited a typical increase in K+
conductance. After exposure to ISO plus ICa,L activation,
ACh2 also elicited a typical potentiated increase in
K+ conductance compared with ACh1. In the
presence of propranolol, the response to ACh3
was similar to that of ACh1; ie, propranolol
selectively blocked ACh3-activated
IK,ATP. In the four cells studied, ACh1 and
ACh2 elicited an increase in K+ current at
-130 mV of 6.3±1.8 and 8.7±2.3 pA/pF, respectively
(P<.5), and at +30 mV the currents were 9.1±1.8 and
12.0±2.1 pA/pF, respectively (P<.01). There were no
significant differences, however, between ACh1- and
ACh3-induced K+ currents. These results
indicate that the effect of ISO to elicit ACh-activated
IK,ATP is mediated via ß-adrenergic receptors.
|
To determine the receptors mediating the effects of ACh, we repeated
the standard protocol of ISO and ICa,L activation in the
presence of 1 µmol/L atropine. Atropine blocked all ACh-induced
changes in current (not shown) (n=2). Although these results indicate
that ACh is acting via muscarinic receptors, they do not distinguish
among multiple subtypes of muscarinic receptors.24 Our
previous work indicated that ACh can act via M2 muscarinic
receptors to activate IK,ACh and via M1
muscarinic receptors to activate
IK,ATP.10 Therefore, as shown in Fig 6B
, we
used pirenzepine, an M1 receptor antagonist, to
determine whether ACh was acting via M1 receptors to elicit
the potentiated K+ current. Pirenzepine (0.2 µmol/L) was
administered throughout both ACh1 and ACh2.
ACh1 elicited a typical increase in K+ current.
After exposure to ISO plus ICa,L activation,
ACh2 failed to elicit the potentiated increase in
K+ current. In the five cells studied, the
ACh1- and ACh2-induced K+ currents
at -130 mV were 13.5±3.5 and 11.5±3.4 pA/pF, respectively, and those
at +30 mV were 19.6±2.3 and 15.5±0.8 pA/pF, respectively. Values at
each voltage were not significantly different from one another. These
results suggest that after exposure to ISO, ACh2 is acting
via M1 receptors to activate
IK,ATP.
If ACh2 is acting via M2 and M1
receptors to activate IK,ACh and
IK,ATP, respectively, then blocking M2
receptors should allow selective ACh2-induced activation of
IK,ATP. As shown in Fig 6C
, the standard protocol was
performed with ISO plus ICa,L activation imposed during the
recovery period. AFDX116 (100 µmol/L), a selective M2
antagonist,25 was administered during the
recovery period and during ACh2. ACh1 elicited
a typical increase in K+ current. In the presence of
AFDX116, however, ACh2 elicited a smaller, rather than
larger, increase in K+ conductance than ACh1 at
voltages both positive and negative to the reversal potential. In
addition, the smaller current induced by ACh2 reversed at
-80 mV and inwardly rectified at positive voltages. In the five
cells studied, ACh1- and ACh2-induced
K+ currents at -130 mV were 8.3±1.5 and 2.1±0.5 pA/pF,
respectively (P<.005), and those at +30 mV were 10.0±1.8
and 2.8±0.3 pA/pF, respectively (P<.01). The
AFDX116-insensitive current induced by ACh2 was
75%
smaller than the ACh1-induced K+ current (see
Table
). In four additional cells, we repeated the same protocol with
100 µmol/L AFDX116 administered throughout both ACh1 and
ACh2. Under these conditions, ACh1 failed to
elicit any change in current, and ACh2 elicited a small
current with features similar to those described in the preceding
experiments.
To determine whether the AFDX116-insensitive current was inhibited by
GLIB, we performed our standard protocol of exposure to ISO and
ICa,L activation during the recovery period and then added
100 µmol/L AFDX116 plus 10 µmol/L GLIB to the external solution
immediately after the administration of ACh1 and during the
recovery period and ACh2 administration (not shown). Under
these conditions, ACh2 failed to activate any
significant increase in current. At -130 mV, ACh1 and
ACh2 elicited an increase in K+ current of
11.5±0.9 and 0.5±0.2 pA/pF, respectively, and at +30 mV, the currents
were 16.2±1.8 and 1.0±0.4 pA/pF, respectively (see Table
). Taken
together, these experiments indicate that after exposure to ISO, ACh is
acting via M1 muscarinic receptors to activate
IK,ATP.
Role of PKC
M1 muscarinic receptors are coupled to PI
hydrolysis,26 the production of DAG, and
stimulation of PKC. Therefore, we determined whether calphostin C, a
selective PKC antagonist,27 could inhibit
ACh2-induced activation of IK,ATP. ISO (1
µmol/L) plus ICa,L activation were imposed during the
recovery period, and calphostin C (0.1 µmol/L) was administered after
ACh1, during the recovery period, and during
ACh2. In the three cells studied, ACh1- and
ACh2-induced increases in K+ current at -130
mV were 11.9±1.6 and 12.0±1.5 pA/pF, respectively, and at +30 mV,
they were 15.8±3.2 and 15.9±2.9 pA/pF, respectively (see Table
).
Values measured at either voltage were not statistically different.
These results indicate that inhibition of PKC selectively abolished
ACh2-activated IK,ATP and support the
idea that ACh is acting via the PI signaling pathway.
| Discussion |
|---|
|
|
|---|
2.5 times smaller than
that in cat ventricular myocytes (authors' unpublished
data, 1994). Assuming that the open probability of the ATP-sensitive
K+ channels activated by DNP is similar in both
tissues, these findings suggest that the density of ATP-sensitive
K+ channels in atrial muscle is significantly lower than in
ventricular muscle. The present findings indicate that the effects of ISO to potentiate ACh-induced increases in K+ current are mediated via cAMP. Thus, the effects of ISO were (1) mediated via ß-adrenergic receptors, (2) mimicked by forskolin and 8-CPT-cAMP, and (3) abolished by inhibition of cAMP-dependent PKA with Rp-cAMPs. Moreover, ISO acted to potentiate ACh-induced K+ current by stimulating both ICa,L and SR Ca2+ uptake. Thus, even though BAY K 8644 increased ICa,L to about the same extent as ISO, it failed to potentiate ACh-induced K+ conductance to the same extent as ISO. This can be explained by the fact that BAY K 8644 is an L-type Ca2+ channel agonist that does not stimulate cAMP and therefore, unlike ISO, does not stimulate SR Ca2+ uptake. Likewise, thapsigargin or ryanodine selectively abolished the effects of ISO on ACh2-activated IK,ATP by depleting SR Ca2+ without decreasing ISO-induced stimulation of ICa,L. These experiments clearly separate the stimulatory effect of ISO on SR Ca2+ uptake from its effect on ICa,L. In addition, the potentiating effect of ISO was significantly diminished or abolished without concomitant ICa,L activation or when ICa,L was blocked by nisoldipine, respectively. In these experiments, the lack of Ca2+ influx via ICa,L also would be expected to attenuate SR Ca2+ uptake. Taken together, these experiments indicate that exposure to ISO conditions the cell through cAMP-induced stimulation of both Ca2+ influx via ICa,L and SR Ca2+ uptake. In addition, the present results support our previous studies,10 in which we concluded that a prolonged ACh exposure conditions atrial cells by loading SR Ca2+.
The present findings also indicate that ACh-induced increases in
K+ conductance are mediated via both M2 and
M1 muscarinic receptors; M2 receptors mediate
activation of IK,ACh, and M1 receptors
mediate activation of IK,ATP. Moreover, the fact that
ACh-induced activation of IK,ATP was dependent on PKC
activity and that M1 receptors mediate PI
hydrolysis26 strongly suggests that after exposure to ISO,
ACh is acting via the PI signaling pathway to activate
IK,ATP. PKC is thought to mediate various intracellular
processes, including regulation of ion channels, via
phosphorylation of protein substrates. It seems
unlikely that PKC was activated directly by ISO rather than by
ACh because
-adrenergic receptors mediate the PI signaling
pathway,28 and in the present study the effects of ISO
were selectively abolished by ß-adrenergic receptor block. Moreover,
these results are consistent with our previous studies showing
that ACh acts via M1 receptors and the PI signaling pathway
to activate IK,ATP and via M2 receptors
to directly activate IK,ACh.10
How does ISO induce ACh to activate IK,ATP? On the
basis of the present findings, it seems reasonable to conclude that
elevated SR Ca2+ induced by ISO- and ACh-induced
stimulation of the PI signaling pathway may operate in concert to
activate IK,ATP. One possible response of
stimulating the PI signaling pathway is the production of
IP3 and the mobilization of intracellular
Ca2+ stores.29 It may be that ACh acts
via IP3 to mobilize Ca2+ stores filled
by prior exposure to ISO, which in turn activates a
Ca2+-dependent PKC to phosphorylate
ATP-sensitive K+ channels. Atrial muscle contains a
Ca2+-dependent PKC-
subtype.30 The
present findings, however, show that ryanodine selectively
abolished ACh-induced activation of IK,ATP. This indicates
that the SR Ca2+ stores filled by ISO are mediated
via ryanodine receptors and not IP3
receptors.31 In addition, the time course of
IP3-induced mobilization of intracellular
Ca2+ may be too slow to account for the ACh-induced
activation of IK,ATP. Alternatively, loading of SR
Ca2+ has been shown to enhance the spontaneous
release of SR Ca2+ from single
Ca2+-release channels, ie, Ca2+
sparks.32 Moreover, Ca2+
sparks32 and the effects of ISO to induce
ACh-activated IK,ATP, as shown in the
present study, are both abolished by ryanodine. Spontaneous SR
Ca2+ release may increase Ca2+
concentrations at selected subsarcolemmal sites that may facilitate
activation of IK,ATP. On the basis of work in
ventricular membrane patches,33 it seems
unlikely that the effects of elevated Ca2+ would be
to alter the sensitivity of ATP-sensitive K+ channels to
inhibition by ATP. However, several steps in the PI signaling pathway,
such as stimulation of membrane-bound phospholipase C and the
hydrolysis of phosphoinositides, are
Ca2+-dependent processes.34 Moreover,
elevated Ca2+ may stimulate
Ca2+-dependent PKC subtypes found in atrial
muscle.30
Therefore, we propose the model shown in Fig 7
. A
resting atrial myocyte exhibits relatively low SR
Ca2+ levels and therefore little, if any,
spontaneous SR Ca2+ release. Under these conditions,
an initial brief exposure to ACh primarily acts via M2
receptors to directly activate IK,ACh. Subsequent
exposure to ISO stimulates cAMP-dependent PKA activity and thereby
enhances Ca2+ influx via ICa,L and SR
Ca2+ uptake. Both mechanisms contribute to elevating
SR Ca2+ levels. By raising SR
Ca2+, ISO enhances spontaneous SR
Ca2+ release and thereby raises
Ca2+ concentrations in restricted subsarcolemmal
spaces. This local Ca2+-enriched environment
facilitates the effects of a second ACh exposure to act via
M1 receptors and the PI signaling pathway. As a result,
ACh2-induced activation of PKC, either
Ca2+ dependent or Ca2+
independent, phosphorylates membrane sites to
activate IK,ATP. Phosphorylation
has been proposed as an element in the activation of
IK,ATP.7 35
|
It is worth noting that the ability of ACh to elicit IK,ATP specifically required an increase in SR Ca2+ rather than simply an increase in cytosolic Ca2+. Thus, the ability of ISO to induce ACh-activated IK,ATP was abolished by agents that specifically deplete SR Ca2+, even though the ISO-induced stimulation of Ca2+ influx via ICa,L was unchanged. Moreover, when Ca2+ influx was increased by activation of basal ICa,L alone or by BAY K 8644, ACh either failed to activate IK,ATP or elicited only a modest activation, respectively. These findings are consistent with our previous studies in which depletion of SR Ca2+ with either caffeine or ryanodine also prevented ACh-induced activation of IK,ATP.10 Therefore, we speculate that the SR may function to distribute Ca2+ to specific subsarcolemmal sites at which Ca2+ can modulate regulation of ATP-sensitive K+ channels via the PI signaling pathway.
In ventricular myocytes, ISO has been shown to augment
IK,ATP but only when IK,ATP has been previously
activated either by pinacidil,36 a K+
channel opener, or by lowering intracellular ATP.37 In the
former study, it was speculated that the effects of ISO were due to
cAMP-dependent phosphorylation of the channel. This
mechanism does not appear to contribute to the present results,
because the effects of ISO to induce ACh-activated
IK,ATP were selectively blocked by agents such as
thapsigargin or ryanodine, which would not be expected to interfere
with ISO-induced stimulation of cAMP. In the latter study, ISO enhanced
IK,ATP by metabolically depleting local
subsarcolemmal ATP levels via stimulation of adenylate
cyclase. This effect of ISO could not be mimicked by direct
stimulation of PKA with 8-CPT-cAMP and only occurred when intracellular
ATP levels were previously lowered below
1 mmol/L. Several of the
present findings make it unlikely that a similar mechanism is
responsible for the effects of ISO to induce ACh-activated
IK,ATP. Thus, the use of the perforated-patch method
precludes the possibility that ATP levels were below 1 mmol/L before
exposure to ISO or that ISO could drop ATP concentrations that low. In
addition, the effects of ISO were mimicked by direct stimulation of PKA
with 8-CPT-cAMP, which would bypass stimulation of adenylate
cyclase. Moreover, the fact that ISO never induced a change in
background current suggests that ISO did not decrease ATP, either
locally or globally, to levels low enough to directly activate
the channel. Furthermore, drugs that specifically abolished the effects
of ISO to induce ACh-activated IK,ATP, such
as ryanodine, would not be expected to influence the ability of ISO to
stimulate adenylate cyclase or to lower ATP. It is also
worth considering that the intracellular ATP concentration that
produces half-maximal inhibition of ATP-sensitive K+
channels is
25 to 100 µmol/L.38 It could be argued
that only a fraction of the channels may need to be activated
to elicit the currents reported in the present study and therefore
may require only a small decrease in intracellular ATP below normal.
This idea has been proposed to explain findings that early
ischemia produces significant shortening in action potential
duration with little change in intracellular ATP
concentrations.38 The present results, however,
indicate that ACh activates as many ATP-sensitive
K+ channels as severe metabolic inhibition
induced by DNP, suggesting that ACh is activating a relatively large
percentage of the available channels. If this response to ACh is
somehow dependent on an ISO-induced depletion of intracellular ATP, it
seems likely that it would have to be a relatively large decrease in
ATP. This seems unlikely given the considerations discussed above.
In terms of cardiac function, cholinergic inhibition is accentuated by the presence of sympathetic stimulation, ie, accentuated antagonism.2 3 At least part of the underlying mechanism is due to cholinergic inhibition of ß-adrenergicinduced stimulation of adenylate cyclase and cAMP.1 The present results demonstrate a novel mechanism of adrenergic-cholinergic interaction that is unrelated to cholinergic inhibition of cAMP. Thus, ß-adrenergic stimulation of cAMP increases SR Ca2+ levels, which in turn enhances ACh-induced increases in K+ conductance. This mechanism may be important in the normal reciprocal interplay between sympathetic and parasympathetic regulation of atrial function. Thus, prior ß-adrenergic stimulation may directly accentuate subsequent cholinergically mediated hyperpolarization and shortening of the action potential duration. In this way, atrial activity enhanced by sympathetic stimulation is effectively antagonized by enhanced cholinergic inhibition of atrial activity. This mechanism may contribute to the antiarrhythmic effects of vagal nerve activity.39 On the other hand, this mechanism may underlie the effect of sympathetic stimulation to enhance atrial flutter rate or initiate atrial fibrillation by shortening atrial refractoriness mediated by vagal nerve stimulation. Finally, the present findings, as well as our previous studies,10 indicate that loading of SR Ca2+ can potentiate ACh-induced increases in K+ conductance via ACh-activated IK,ATP. This represents a fundamentally new mechanism of cholinergic regulation that has wide implications with respect to the way in which drugs, neurotransmitters, and physiological or pathophysiological states that modulate SR Ca2+ may also modulate ACh-induced activation of ATP-sensitive K+ channels.
| Selected Abbreviations and Acronyms |
|---|
|
| Acknowledgments |
|---|
Received December 27, 1994; accepted May 12, 1995.
| References |
|---|
|
|
|---|
2. Levy MN. Cardiac sympathetic-parasympathetic interactions. Fed Proc. 1984;43:2598-2602. [Medline] [Order article via Infotrieve]
3. Levy MN, Pappano AJ. Vagal control of myocardial contractility. In: Levy MN, Schwartz PJ, eds. Vagal Control of the Heart: Experimental Basis and Clinical Implications. Armonk, NY: Futura Publishing Co Inc; 1994:241-259.
4. Sakmann B, Noma A, Trautwein W. Acetylcholine activation of single muscarinic K channels in isolated pacemaker cells of the mammalian heart. Nature. 1983;303:250-253. [Medline] [Order article via Infotrieve]
5. Brown AM. Coupling of G-proteins to cardiac ion channels. In: Levy MN, Schwartz PJ, eds. Vagal Control of the Heart: Experimental Basis and Clinical Implications. Armonk, NY: Futura Publishing Co Inc; 1994:133-146.
6. Kurachi Y, Tung RT, Ito H, Nakajima T. G protein activation of cardiac muscarinic K+ channels. Prog Neurobiol. 1992;39:229-246. [Medline] [Order article via Infotrieve]
7.
Ito H, Tung RT, Sugimoto T, Kobayashi I, Takahashi K,
Katada T, Ui M, Kurachi Y. On the mechanism of G protein ß
gamma subunit activation of the muscarinic K+ channel in
guinea pig atrial cell membrane. J Gen
Physiol. 1992;99:961-983.
8.
Ito H, Vereecke J, Carmeliet E. Mode of
regulation by G protein of the ATP-sensitive K+ channel in
guinea-pig ventricular cell membrane. J
Physiol (Lond). 1994;478:101-108.
9. Wang YG, Lipsius SL. Acetylcholine potentiates acetylcholine-induced increases in K+ current in cat atrial myocytes. Am J Physiol. 1994;37:H1313-H1321.
10. Wang YG, Lipsius SL. Acetylcholine activates a glibenclamide-sensitive K+ current in cat atrial myocytes. Am J Physiol. 1995;37:H1322-H1334.
11. Zhou Z, Lipsius SL. Effect of isoprenaline on If current in latent pacemaker cells isolated from cat right atrium: ruptured vs perforated patch whole-cell recording methods. Pflugers Arch. 1993;423:442-447. [Medline] [Order article via Infotrieve]
12.
Horn R, Marty A. Muscarinic activation of ionic
currents measured by a new whole-cell recording method.
J Gen Physiol. 1988;92:145-159.
13.
Wu J, Vereecke J, Carmeliet E, Lipsius SL. Ionic
currents activated during hyperpolarization
of single right atrial myocytes from cat heart.
Circ Res. 1991;68:1059-1069.
14. Hamill OP, Marty A, Neher E, Sakmann B, Sigworth FJ. Improved patch-clamp techniques for high resolution current recording from cells and cell-free membrane patches. Pflugers Arch. 1981;391:85-100. [Medline] [Order article via Infotrieve]
15.
Zhou Z, Lipsius SL. Properties of the pacemaker
current (If) in latent pacemaker cells isolated from cat
right atrium. J Physiol (Lond). 1992;453:503-523.
16. Escande D. The pharmacology of ATP-sensitive K+ channels in the heart. Pflugers Arch. 1989;414:S93-S98.
17. Hamada E, Takikawa R, Ito H, Iguchi M, Terano A, Sugimoto T, Kurachi Y. Glibenclamide specifically blocks ATP-sensitive K+ channel current in atrial myocytes of guinea pig heart. Jpn J Physiol. 1990;54:473-477.
18. Noma A. ATP-regulated K+ channels in cardiac muscle. Nature. 1983;305:147-148. [Medline] [Order article via Infotrieve]
19.
Wilde AAM, Escande D, Schumacher CA, Thuringer D,
Mestre M, Fiolet JWT, Janse MJ. Potassium accumulation in the
globally ischemic mammalian heart. Circ
Res. 1990;67:835-843.
20. Schramm M, Thomas G, Towart R, Franckowiak G. Novel dihydropyridines with positive inotropic action through activation of Ca++ channels. Nature. 1983;303:535-537. [Medline] [Order article via Infotrieve]
21. Janczewski AM, Lakatta EG. Thapsigargin inhibits Ca2+ uptake, and Ca2+ depletes sarcoplasmic reticulum in intact cardiac myocytes. Am J Physiol. 1993;34:H517-H522.
22. Rousseau E, Smith JS, Meissner G. Ryanodine modifies conductance and gating behavior of single Ca2+ release channel. Am J Physiol. 1987;22:C364-C368.
23.
Van Haastert PJM, Van Driel R, Jastorff B, Baraniak J,
Stec WJ, De Wit RJW. Competitive cAMP antagonist for
cAMP-receptor proteins. J Biol Chem. 1984;259:10020-10024.
24. Ashkenazi A, Peralta EG. Muscarinic acetylcholine receptors. In: Peroutka SJ, ed. Handbook of Receptors and Channels: G-Protein Coupled Receptors. Boca Raton, Fla: CRC Press; 1994:1-27.
25.
Ehlert FJ, Delen FM, Yun SH, Friedman DJ, Self DW.
Coupling of subtypes of the muscarinic receptor to
adenylate cyclase in the corpus striatum and heart.
J Pharmacol Exp Ther. 1989;251:660-671.
26. Peralta EG, Ashkenazi A, Winslow JW, Ramachandran J, Capon DJ. Differential regulation of PI hydrolysis and adenylyl cyclase by muscarinic receptor subtypes. Nature. 1988;334:434-437. [Medline] [Order article via Infotrieve]
27. Kobayashi E, Nakano H, Morimoto M, Tamaoki T. Calphostin C (UCN-1028C), a novel microbial compound, is a highly potent and specific inhibitor of protein kinase C. Biochem Biophys Res Commun. 1989;159:548-553. [Medline] [Order article via Infotrieve]
28. Brown JH, Masters SB. Muscarinic regulation of phosphatidylinositol turnover and cyclic nucleotide metabolism in the heart. Fed Proc. 1984;43:2613-2617. [Medline] [Order article via Infotrieve]
29. Vites A, Pappano A. Inositol 1,4,5-trisphosphate release intracellular Ca2+ in permeabilized chick atria. Am J Physiol. 1990;27:H1745-H1752.
30.
Rybin VO, Steinberg SF. Protein kinase C isoform
expression and regulation in the developing rat heart.
Circ Res. 1994;74:299-309.
31. Ehrlich BE, Kaftan E, Bezprozvannaya S, Bezprozvanny I. The pharmacology of intracellular Ca2+-release channels. Trends Pharmacol Sci. 1994;15:145-149. [Medline] [Order article via Infotrieve]
32.
Cheng H, Lederer WJ, Cannell MB. Calcium sparks:
elementary events underlying excitation-contraction coupling in heart
muscle. Science. 1993;262:740-744.
33.
Deutsch N, Weiss JN. ATP-sensitive
K+ channel modification by metabolic inhibition
in isolated guinea-pig ventricular myocytes.
J Physiol (Lond). 1993;465:163-179.
34. Brown SL, Brown JH. Muscarinic stimulation of phosphatidylinositol metabolism in atria. Mol Pharmacol. 1983;24:351-356. [Abstract]
35. Findlay I. Effects of ADP upon the ATP-sensitive K+ channel in rat ventricular myocytes. J Membr Biol. 1988;101:83-92. [Medline] [Order article via Infotrieve]
36. Tseng G-N, Hoffman BF. Actions of pinacidil on membrane currents in canine ventricular myocytes and their modulation by intracellular ATP and cAMP. Pflugers Arch. 1990;15:414-424.
37.
Schackow TE, Ten Eick RE. Enhancement of
ATP-sensitive potassium current in cat ventricular myocytes
by ß-adrenoreceptor stimulation.
J Physiol (Lond). 1994;474:131-145.
38. Nichols CG, Lederer WJ. Adenosine triphosphate-sensitive potassium channels in the cardiovascular system. Am J Physiol. 1991;30:H1675-H1686.
39. Wharton JM, Coleman RE, Strauss HC. The role of the autonomic nervous system in sudden cardiac death. Trends Cardiovasc Med. 1992;2:65-71.
This article has been cited by other articles:
![]() |
J. R. Ehrlich, T.-J. Cha, L. Zhang, D. Chartier, L. Villeneuve, T. E. Hebert, and S. Nattel Characterization of a hyperpolarization-activated time-dependent potassium current in canine cardiomyocytes from pulmonary vein myocardial sleeves and left atrium J. Physiol., June 1, 2004; 557(2): 583 - 597. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. G. Wang, E. N. Dedkova, S. F. Steinberg, L. A. Blatter, and S. L. Lipsius {beta}2-Adrenergic Receptor Signaling Acts via No Release to Mediate Ach-Induced Activation of Atp-Sensitive K+ Current in Cat Atrial Myocytes J. Gen. Physiol., January 1, 2002; 119(1): 69 - 82. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Mullner, D. Vorobiov, A. K. Bera, Y. Uezono, D. Yakubovich, B. Frohnwieser-Steinecker, N. Dascal, and W. Schreibmayer Heterologous Facilitation of G Protein-Activated K+ Channels by {beta}-Adrenergic Stimulation via Camp-Dependent Protein Kinase J. Gen. Physiol., May 1, 2000; 115(5): 547 - 558. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Carmeliet Cardiac Ionic Currents and Acute Ischemia: From Channels to Arrhythmias Physiol Rev, July 1, 1999; 79(3): 917 - 1017. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Babenko and G. Vassort Enhancement of the ATP-Sensitive K+ Current by Extracellular ATP in Rat Ventricular Myocytes : Involvement of Adenylyl Cyclase–Induced Subsarcolemmal ATP Depletion Circ. Res., April 19, 1997; 80(4): 589 - 600. [Abstract] [Full Text] |
||||
![]() |
M.-C. Wellner-Kienitz, K. Bender, and L. Pott Overexpression of beta 1 and beta 2 Adrenergic Receptors in Rat Atrial Myocytes. DIFFERENTIAL COUPLING TO G PROTEIN-GATED INWARD RECTIFIER K+ CHANNELS VIA Gs AND Gi/o J. Biol. Chem., September 28, 2001; 276(40): 37347 - 37354. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Circulation Research Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1995 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |